Using bar-code verification technology within an electronic medication administration system substantially reduces transcription and medication administration errors along with related potential drug-related adverse events, according to a new study.
Using bar-code verification technology within an electronic medication administration system (bar-code eMAR) substantially reduces transcription and medication administration errors along with related potential drug-related adverse events, according to a study from Brigham and Women's Hospital.
Investigators observed more than 14,000 medication administrations and reviewed more than 3,000 order transcriptions at Brigham and Women's Hospital.
In hospital units that did not use the bar-code eMAR, researchers observed 776 nontiming errors in medication administration (11.5% error rate) compared with 495 such errors (6.8% error rate) on units used the technology-a 41% relative reduction in errors (P<.001).
In addition, although transcription errors occurred at a rate of 6.1% on units without bar-code eMAR, they were completely eliminated on units that did use the technology.
Poon EG, Keohane CA, Yoon CS, et al. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010;362(18):1698-1707.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More